Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Pediatric Solid-organ Transplant Recipients-Reference-Cited by-同舟云学术

Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Pediatric Solid-organ Transplant Recipients

Published:2017-08 Issue:8 Volume:36 Page:745-750
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Peled Orit,Berkovitch Matitiahu,Rom Eran,Bilavsky Efraim,Bernfeld Yael,Dorfman Lev,Pappo Adi,Ziv-Baran Tomer,Brandriss Nurit,Bar-Haim Adina,Amir Jacob,Ashkenazi-Hoffnung Liat

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference27 articles.

1. Cytomegalovirus in solid organ transplant recipients.;Humar;Am J Transplant,2009

2. Valganciclovir: an advance in cytomegalovirus therapeutics.;Cocohoba;Ann Pharmacother,2002

3. Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients.;Pescovitz;Antimicrob Agents Chemother,2000

4. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients.;Asberg;Am J Transplant,2007

5. Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients.;Wiltshire;Clin Pharmacokinet,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valganciclovir and Risk for Neutropenia: When the Friend Becomes the Foe;Pediatric Transplantation;2024-07-19

2. Valacyclovir or valganciclovir for cytomegalovirus prophylaxis: A randomized controlled trial in adult and pediatric kidney transplant recipients;Journal of Clinical Virology;2024-06

3. Optimization of Ganciclovir and Valganciclovir Starting Dose in Children by Machine Learning;Clinical Pharmacokinetics;2024-03-16

4. Evaluation of valganciclovir's neutropenia risk in pediatric solid organ transplant recipients utilizing two dosing regimens;Pediatric Transplantation;2024-02-29

5. Current and Emerging Antiviral Agents in the Prevention and Treatment of Cytomegalovirus in Pediatric Transplant Recipients;Journal of the Pediatric Infectious Diseases Society;2024-02-01